Immunome, Inc Earning Date (IMNM)

USA |NASDAQ |USD

IMNM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 23, 2022 Dec 2021 $-0.81 - $-0.40
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 23, 2022 Dec 2021 $0.00 - $0.00

Immunome, Inc's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 2021.

IMNM Earnings Date & History Chart

IMNM Earnings & Revenue Forecast

IMNM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $-3.11 $-3.11 $-3.11

IMNM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-1.86 $-1.86 $-1.86

IMNM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $0.00 $0.00 $0.00

IMNM Earnings Date & Revenue History

IMNM Earnings History

|
Show More
Show More

IMNM Revenue History

|
Show More
Show More

Immunome, Inc Next Earnings Date & Report

IMNM Next Earnings Date & Report Preview: Dec 2021 (FQ)

IMNM's next earnings date is Wednesday, Mar 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Immunome, Inc's next quarterly earnings is $-0.81, with a low EPS estimation of $-0.81, and a high estimation of $-0.81.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.44, the last 2 month trend is $-0.44, and the 3 month trend is $-0.44.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Immunome, Inc Previous Earnings Dates & Reports

IMNM Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Immunome, Inc's previous earnings date was Nov 15, 2021 for its fiscal quarter ended Sep 30, 2021.

IMNM Previous Earnings Date & Report Recap: Dec 2020 (FY)

Immunome, Inc's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

IMNM's earnings per share (EPS) was $-7.92.

Revenues were $0.00.

The company reported a net income of $-17.84M.

Immunome, Inc reported a free cash flow of $-12.72M for its fiscal year, compared to $-9.83M a year ago.

The company ended the fiscal year with $613.00K in total debt, an increase of 8.69% compared to the previous year.